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SUMMARY 
The effect of long-term lithium carbonate treatment on thyroid function was investigated in 40 cli-
nically euthyroid patients with M^nic Depressive Psychosis. Before lithium treatment, all patients showed 
normal levels (T4) of serum total thyioxine, free thyroxine index and thyrotropin (TSH). After lithium car-
bonate treatment for a mean period of 24 months, these patients did not shew any significant change in the 
mean values of serum total 'i\, free thyroxine index and TSH. None showed clinical symptoms of goitre 
and hypothyroidism>fter long-term lithium treatment. It is concluded that lithium therapy in euthyroid 
psychiatric patients has no adverse effect on thyroid function and en the pituitary secretion of TSH. 
Lithium salts have been increasingly 
used in the treatment of patients with 
psychiatric illnesses. The toxic effects of 
lithium have been well documented and, 
of the various endocrine and metabolic 
effects reported to date, thyroid dysfunc-
tion has received the most widespread 
attention. Lithium carbonate treatment 
in psychiatric patients was found to induce 
a fall in serum total thyroxine (T<), 
(Emerson et at., 1973) and an elevation in 
serum thyrotropin (TSH) (Lazarus and 
Bennie, 1972; Emerson et at., 1973). 
In addition, the development of goitre 
(Schou et at., 1968) and clinically evident 
hypothyroidism (Luby et at., 1971; Rogers 
and Wybrow 1971; Candy, 1972) have 
been occasionally observed during lithium 
therapy. On the other hand, we have 
noticed that lithium treatment in clinically 
euthyroid psychiatric patients did not show 
any significant alteration in thyroid func-
tion. The details are reported in this 
communication. 
MATERIALS & METHODS 
40 psychiatric patients (30 males and 
10 females) between the ages of 20 and 
60 years were the subjects of the study. 
^Professor of Psychiatry, 
•Senior Biochemist, V Christian Medical College & Hospital, Vellore. 
•Professor of Biochemistry, J 
They attended the psychiatry unit of 
Christian Medical College Hospital for 
treatment of recurrent episodes of Manic 
Depressive Psychosis. Those who gave a 
history of having had 3 or more major 
episodes of mania and/or depression in the 
previous 2 years were taken up for pro-
phylactic treatment with lithium carbo-
nate. 26 of them had both recurrent 
manic and depressive episodes, 10 had 
only recurrent manic episodes, while 4 
gave only a hisotry of recurrent 
depression. 
Those who came in a state of depre-
ssion (18 in number) were treated for the 
current episode, with iricyclic antidepre-
ssants and after the depressed mood im-
proved, they were started on lithium as a 
prophylactic. 22 patients who came in a 
state of mania or hypomania were ini-
tially treated with phenothiazines for the 
control of manic symptoms and within a 
few days they were also given lithium both 
for the control of the current manic epi-
sode as well as for prevention of future 
episodes. Once lithium reached an effec-
tive level, the phenothiazines were gradu-
ally tapered off and later was used only for 
brief periods in 5 of these patients in EFFECTS OF LONG-TERM LlTHItTM CARBONATE TREATMENT 99 
whom recurrence occurred despite lithium 
treatment. Only those who had been on 
long term lithium treatment for at least 
two years were studied. 
All subjects were medically evaluated 
and showed no evidence of significant 
liver, cardiac or renal disease. They were 
without goitre and had no sign of thyroid 
disorders. Subsequent medical examina-
tion and investigations indicated that all 
of them were euthyroid as well. 
The dosage of lithium was 600 to 1800 
mg., daily, and serum lithium concen-
tration was 0.83 ±0.20 mEq/1. Blood 
samples were collected before and after 
lithium treatment for thyroid function 
studies. Serum T4 and TSH were mea-
sured by specific and sensitive radio immu-
noassays and the methodological details 
were described in an earlier report from 
our laboratory (Neela et al., 1981). Using 
Sephadex T3 uptake test, free thyroxine 
index was calculated. Fifty healthy con-
trol subjects studied by us earlier (Neela 
et al., 1981) were used for comparison. 
TABLE 1. Effect of Lithium on Thyroid 
function tests in psychiatric patients 
T, Free Thyroxine TSH 
Group (nmol/1) index (nU/ml) 
Psychiatric 
patients (N=40) 
Before lithium 114±19 116-fcl9 4.2±2.1 
Afterlithium 111±23 112±25 4.3-£1.6 
•Control subjects 
(N=50) 113±24 U7-£24 4A±\.B 
Each value represents the Mean-J- Standard 
dexiation 
Comparison between the values before and after 
lithium treatment was made, and no significant 
difference was established. 
•Referred from our previous report (Neela et al., 
1981). 
As shown in the table, before starting 
the lithium treatment, all euthyroid psy-
chiatric patients had serum total Tti free 
thyroxine index and TSH comparable to 
that seen in control subjects. After lithi-
um therapy none of our psychiatric patients 
showed an elevation of serum TSH level 
above the reference range (0.8—8.0 uU/ 
ml) of control subjects. Serum T4 level 
also did not fall below the reference range 
of control group (65—161 nmol/1). The 
mean values of serum Tt, free thyroxine 
index, and TSH did not alter significantly 
after lithium treatment, compared to base-
line levels. None of our patients had 
symptoms of clinical hypothyroidism or 
goitre during the course of lithium treat-
ment. 
DISCUSSION 
A major finding in the present study 
is that there was no evidence of clinical or 
biochemical hypothyroidism after lithium 
therapy. It has been reported earlier 
(Emerson et al., 1972) that the mean serum 
TSH in the lithium treated group was three 
times higher than in the control group, 
and elevated TSH levels occurred in 30% 
of the patients at some time during treat-
ment. Also, Lazarus and Bennie (1972), 
noticed that there was a rise in plasma 
TSH level in 13 manic-depressive patients 
on lithium for three months and another 
12 patients who had been on lithium for 
20 months exhibited still higher TSH levels 
than the values of the former group. In 
the present study, the mean serum TSH 
value after lithium treatment did not alter 
significantly when compared with pre-
treatment level or with healthy control 
subjects. None of our patients showed 
an increase in serum TSH level above the 
reference range of control subjects during 
lithium therapy. The patients on lithium 
treatment in our study were reassessed for 
thyroid function after long-term lithium 
carbonate treatment (Minimum period 100  K. KURUVILLA, ,1 al. 
24 months). But none showed any signs 
of clinical or biochemical hypothyroidism. 
Regarding the possible effect of 
lithium on circulating thyroid hormones, 
Rifkin et al. (1974), while comparing the 
6 weeks lithium treatment period with 
placebo period in psychiatric patients 
noticed a significant drop in the mean 
serum T4 level after lithium intake. Co-
oper and Simpson (1969) also found that 
the mean PBI and free T4 levels were 
significantly reduced in 25 manic-depre-
ssives when compared with 139 other 
psychiatric admissions. On the other 
hand, it has been reported (Emerson et 
al, 1973; Burrow et al., 1971) that after 
about one to eight months lithium treat-
ment, there was a noticeable but statisti-
cally insignificant fall in serum T4 concen-
tration in manic-depressive patients. The 
present study in agreement with these 
authors, shows a slight but not significant 
fall in serum Tt and free thyroxine index 
when compared with pre-treatment level 
and with control subjects. 
The mechanism of action of lithium 
on thyroid gland remains unclear. Li-
thium alone was found to decrease the 
I
m release by 30 to 85% in thyrotoxic 
patients treated with lithium carbonate 
(Temple et al., 1972). Evidence that 
lithium accumulate within the thyroid 
gland generally achieving a level of 3 to 
5 times that in the serum and that lithium 
inhibits the release of iodine from ihyroid 
was also demonstrated (Burrow et al., 
1971). Aslight reduction of serum T4 and 
free thyroxine ii.dex noticed by us might 
reflect such influences of lithium on the 
thyroid gland. The evidence is indirect 
and must stand as a tentative hypothesis. 
However, our findings support the conclu-
sion that lithium therapy has no adverse 
effect on thyroid function and on the 
pituitary secretion of TSH in clinically 
euthyroid psychiatric patients. 
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